ICON Plc - Company Profile
Powered by 
All the sales intelligence you need on ICON Plc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how ICON Plc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with ICON Plc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
ICON Plc (ICON) is a contract research organization (CRO) that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide. The company provides specialized services that span the entire lifecycle of product development. ICON’s service portfolio includes clinical solutions, blended solutions, cardiac safety solutions, clinical and scientific operations, decentralised clinical trials, early clinical laboratories, medical imaging, site & patient solutions, strategic solutions. The company offers research services in areas of cancer, genomics, central nervous system, cardiovascular, endocrine and metabolic disorders, gastrointestinal, medical device, non-alcoholic steatohepatitis (NASH), ophthalmology, rare and orphan diseases, transplant and immunology, vaccines, and women’s health, among others. ICON is headquartered in Dublin, Ireland.
Headquarters
Ireland
Address
South County Business Park Leopardstown, Dublin, D18X5R3
Website
www.iconplc.com
Telephone
353 1 2912000
No of Employees
40,350
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
ICLR (NASD)
Revenue (2024)
$8.3B
0.8%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-69%
(2024 vs 2023)
Market Cap*
$12.7B
Net Profit Margin (2024)
XYZ
-69.2%
(2024 vs 2023)
* As of and is in US$
ICON Plc premium industry data and analytics
Products and Services
| Services |
|---|
| Clinical Research Services |
| Clinical Solutions: |
| Adaptive Trials |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Contracts/Agreements | In June, the company selected Microsoft as a preferred technology partner to invest in digital innovation and AI over the next three years. |
| 2026 | Contracts/Agreements | In June, the company partnered with the Department of Veterans’ Affairs to deliver the new wellbeing agency website for veterans and their families. |
| 2026 | Corporate Changes/Expansions | In May, the company announced the opening of a new, state-of-the-art Clinical Research Unit (CRU) in San Antonio, Texas. |
Competitor Comparison
| Key Parameters | ICON Plc | Thermo Fisher Scientific Inc | IQVIA Holdings Inc | Almac Group Ltd | Fortrea Inc |
|---|---|---|---|---|---|
| Headquarters | Ireland | United States of America | United States of America | United Kingdom | United States of America |
| City | Dublin | Waltham | Durham | Craigavon | Durham |
| State/Province | Dublin | Massachusetts | North Carolina | Northern Ireland | North Carolina |
| No. of Employees | 40,350 | 125,000 | 93,000 | 7,800 | - |
| Entity Type | Public | Public | Public | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Ciaran Murray | Chairman | Executive Board | 2017 | 63 |
| Barry Balfe | Chief Executive Officer; Director | Executive Board | 2025 | 47 |
| Diarmaid Cunningham | Director; Secretary; Chief Administrative Officer; General Counsel | Executive Board | 2016 | 50 |
| Nigel Clerkin | Chief Financial Officer | Senior Management | 2024 | 52 |
| Tom O'Leary | Chief Information Officer | Senior Management | 2001 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer